{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T03:31:28Z","timestamp":1786505488233,"version":"build-2736575974"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,7]],"date-time":"2026-06-07T00:00:00Z","timestamp":1780790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T00:00:00Z","timestamp":1786492800000},"content-version":"vor","delay-in-days":66,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"European Union Horizon Europe program","award":["101046041"],"award-info":[{"award-number":["101046041"]}]},{"name":"European Union Horizon Europe program","award":["101046041"],"award-info":[{"award-number":["101046041"]}]},{"name":"European Union Horizon Europe program","award":["101046041"],"award-info":[{"award-number":["101046041"]}]},{"name":"European Union Horizon Europe program","award":["101046041"],"award-info":[{"award-number":["101046041"]}]},{"name":"European Union Horizon Europe program","award":["101046041"],"award-info":[{"award-number":["101046041"]}]},{"name":"European Union Horizon Europe program","award":["101046041"],"award-info":[{"award-number":["101046041"]}]},{"name":"European Union Horizon Europe program","award":["101046041"],"award-info":[{"award-number":["101046041"]}]},{"name":"European Union Horizon Europe program","award":["101046041"],"award-info":[{"award-number":["101046041"]}]},{"name":"European Union Horizon Europe program","award":["101046041"],"award-info":[{"award-number":["101046041"]}]},{"name":"European Union Horizon Europe program","award":["101046041"],"award-info":[{"award-number":["101046041"]}]},{"name":"European Union Horizon Europe program","award":["101046041"],"award-info":[{"award-number":["101046041"]}]},{"name":"European Union Horizon Europe program","award":["101046041"],"award-info":[{"award-number":["101046041"]}]},{"name":"European Union Horizon Europe program","award":["101046041"],"award-info":[{"award-number":["101046041"]}]},{"name":"European Union Horizon Europe program","award":["101046041"],"award-info":[{"award-number":["101046041"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol J"],"DOI":"10.1186\/s12985-026-03214-1","type":"journal-article","created":{"date-parts":[[2026,6,7]],"date-time":"2026-06-07T11:05:18Z","timestamp":1780830318000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["SARS-CoV-2 mRNA XBB1.5 vaccine immunogenicity in kidney transplant recipients"],"prefix":"10.1186","volume":"23","author":[{"given":"Mathieu","family":"Sur\u00e9naud","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aur\u00e9lie","family":"Wiedemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hakim","family":"Hocini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emile","family":"Foucat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile","family":"Lefebvre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tugba","family":"Agyar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Jousseaume","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascaline","family":"Tisserand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9line","family":"Pellaton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Millicent","family":"Omondi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy","family":"Burgers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Pantaleo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Durrbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves","family":"L\u00e9vy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,7]]},"reference":[{"key":"3214_CR1","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.1681\/ASN.2020050639","volume":"31","author":"M Elias","year":"2020","unstructured":"Elias M, Pievani D, Randoux C, Louis K, Denis B, Delion A, Le Goff O, Antoine C, Greze C, Pillebout E, Abboud I, Glotz D, Daugas E, Lefaucheur C. COVID-19 Infection in Kidney Transplant Recipients: Disease Incidence and Clinical Outcomes. J Am Soc Nephrol. 2020;31:2413\u201323.","journal-title":"J Am Soc Nephrol"},{"key":"3214_CR2","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1111\/ajt.16424","volume":"21","author":"S Caillard","year":"2021","unstructured":"Caillard S, Chavarot N, Francois H, Matignon M, Greze C, Kamar N, Gatault P, Thaunat O, Legris T, Frimat L, Westeel PF, Goutaudier V, Jdidou M, Snanoudj R, Colosio C, Sicard A, Bertrand D, Mousson C, Bamoulid J, Masset C, Thierry A, Couzi L, Chemouny JM, Duveau A, Moal V, Blancho G, Grimbert P, Durrbach A, Moulin B, Anglicheau D, Ruch Y, Kaeuffer C, Benotmane I, Solis M, LeMeur Y, Hazzan M, Danion F. French SOT COVID Registry. Is Covid-19 infection more severe in kidney transplant recipients? Am J Transpl. 2021;21:1295\u2013303.","journal-title":"Am J Transpl"},{"key":"3214_CR3","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1111\/ajt.17054","volume":"22","author":"L Benning","year":"2022","unstructured":"Benning L, Morath C, Bartenschlager M, Kim H, Reineke M, Beimler J, Buylaert M, Nusshag C, K\u00e4lble F, Reichel P, T\u00f6llner M, Schaier M, Klein K, Benes V, Rausch T, Rieger S, Stich M, T\u00f6nshoff B, Weidner N, Schnitzler P, Zeier M, S\u00fcsal C, Tran TH, Bartenschlager R, Speer C. Neutralizing antibody response against the B.1.617.2 (delta) and the B.1.1.529 (omicron) variants after a third mRNA SARS-CoV-2 vaccine dose in kidney transplant recipients. Am J Transpl. 2022;22:1873\u201383.","journal-title":"Am J Transpl"},{"key":"3214_CR4","doi-asserted-by":"publisher","first-page":"2565","DOI":"10.3390\/jcm11092565","volume":"11","author":"B Osmanodja","year":"2022","unstructured":"Osmanodja B, Ronicke S, Budde K, Jens A, Hammett C, Koch N, Seelow E, Waiser J, Zukunft B, Bachmann F, Choi M, Weber U, Ebersp\u00e4cher B, Hofmann J, Grunow F, Mikhailov M, Liefeldt L, Eckardt KU, Halleck F, Schrezenmeier E. Serological Response to Three, Four and Five Doses of SARS-CoV-2 Vaccine in Kidney Transplant Recipients. J Clin Med. 2022;11:2565.","journal-title":"J Clin Med"},{"key":"3214_CR5","doi-asserted-by":"publisher","first-page":"100178","DOI":"10.1016\/j.lanepe.2021.100178","volume":"9","author":"J Stumpf","year":"2021","unstructured":"Stumpf J, Siepmann T, Lindner T, Karger C, Schw\u00f6bel J, Anders L, Faulhaber-Walter R, Schewe J, Martin H, Schirutschke H, Barnett K, H\u00fcther J, M\u00fcller P, Langer T, Pluntke T, Anding-Rost K, Meistring F, Stehr T, Pietzonka A, Escher K, Cerny S, Rothe H, Pistrosch F, Seidel H, Paliege A, Beige J, Bast I, Steglich A, Gembardt F, Kessel F, Kr\u00f6ger H, Arndt P, Sradnick J, Frank K, Klimova A, Mauer R, Gr\u00e4hlert X, Anft M, Blazquez-Navarro A, Westhoff TH, Stervbo U, Tonn T, Babel N, Hugo C. Humoral and cellular immunity to SARS-CoV-2 vaccination in renal transplant versus dialysis patients: A prospective, multicenter observational study using mRNA-1273 or BNT162b2 mRNA vaccine. Lancet Reg Health Eur. 2021;9:100178.","journal-title":"Lancet Reg Health Eur"},{"key":"3214_CR6","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1097\/TP.0000000000003983","volume":"106","author":"JSF Sanders","year":"2022","unstructured":"Sanders JSF, Bemelman FJ, Messchendorp AL, Baan CC, van Baarle D, van Binnendijk R, Diavatopoulos DA, Fr\u00f6lke SC, Geers D, GeurtsvanKessel CH, den Hartog G, van der Heiden M, Imhof C, Kho MML, Koopmans MPG, Malahe SRK, Mattheussens WB, van der Molen R, van Mourik D, Remmerswaal EBM, Rots N, Vart P, de Vries RD, Gansevoort RT, Hilbrands LB, Reinders MEJ. RECOVAC Collaborators. The RECOVAC Immune-response Study: The Immunogenicity, Tolerability, and Safety of COVID-19 Vaccination in Patients With Chronic Kidney Disease, on Dialysis, or Living With a Kidney Transplant. Transplantation. 2022;106:821\u201334.","journal-title":"Transplantation"},{"key":"3214_CR7","doi-asserted-by":"crossref","unstructured":"Grupper A, Rabinowich L, Ben-Yehoyada M, Katchman E, Baruch R, Freund T, Hagin D, Ben Shlomo S, Schwartz D, Schwartz IF, Shashar M, Kliuk-Ben Bassat O, Halperin T, Turner D, Saiag E, Goykhman Y, Shibolet O, Levy S, Houri I, Katchman H. Humoral Response to the Third Dose of Sars-Cov-2 Vaccine in Kidney Transplant Recipients. Transplant Proc. 2022;54:1439-45.","DOI":"10.1016\/j.transproceed.2022.02.011"},{"key":"3214_CR8","doi-asserted-by":"publisher","first-page":"978764","DOI":"10.3389\/fmed.2022.978764","volume":"9","author":"A Wiedemann","year":"2022","unstructured":"Wiedemann A, Pellaton C, Dekeyser M, Guillaumat L, D\u00e9chenaud M, Krief C, Lacabaratz C, Grimbert P, Pantaleo G, L\u00e9vy Y, Durrbach A. Longitudinal evaluation of the impact of immunosuppressive regimen on immune responses to COVID-19 vaccination in kidney transplant recipients. Front Med. 2022;9:978764.","journal-title":"Front Med"},{"key":"3214_CR9","doi-asserted-by":"publisher","first-page":"4043","DOI":"10.1111\/ajt.16814","volume":"21","author":"N Chavarot","year":"2021","unstructured":"Chavarot N, Morel A, Leruez-Ville M, Vilain E, Divard G, Burger C, Serris A, Sberro-Soussan R, Martinez F, Amrouche L, Bererhi L, Lanternier F, Legendre C, Zuber J, Anglicheau D, Scemla A. Weak antibody response to three doses of mRNA vaccine in kidney transplant recipients treated with belatacept. Am J Transpl. 2021;21:4043\u201351.","journal-title":"Am J Transpl"},{"key":"3214_CR10","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1093\/ckj\/sfac249","volume":"16","author":"P Bouwmans","year":"2022","unstructured":"Bouwmans P, Messchendorp AL, Imhof C, Sanders JSF, Hilbrands LB, Reinders MEJ, Vart P, Bemelman FJ, Abrahams AC, van den Dorpel RMA, Ten Dam MAGJ, de Vries APJ, Rispens T, Steenhuis M, Gansevoort RT, Hemmelder MH, RECOVAC Collaborators. Impact of immunosuppressive treatment and type of SARS-CoV-2 vaccine on antibody levels after three vaccinations in patients with chronic kidney disease or kidney replacement therapy. Clin Kidney J. 2022;16:528\u201340.","journal-title":"Clin Kidney J"},{"key":"3214_CR11","doi-asserted-by":"crossref","unstructured":"L\u00f3pez V, Polo C, Schuldt R, V\u00e1zquez T, Guti\u00e9rrez-V\u00edlchez E, Moliz C, Hern\u00e1ndez D. Humoral Response After SARS-CoV-2 Vaccination in Kidney Transplant Recipients: Role of Immunosuppression Therapy. Transplant Proc. 2022;54:2454-6.","DOI":"10.1016\/j.transproceed.2022.09.019"},{"key":"3214_CR12","doi-asserted-by":"crossref","unstructured":"P\u00e9rez-Flores I, Juarez I, Aiffil Meneses AS, Lopez-Gomez A, Calvo Romero N, Rodriguez-Cubillo B, de la Moreno MA, Peix-Jim\u00e9nez B, Gonzalez-Garcia R, Baos-Mu\u00f1oz E, Arribi Vilela A, G\u00f3mez, Del Moral M, Mart\u00ednez-Naves E, Sanchez-Fructuoso AI. Role of mTOR inhibitor in the cellular and humoral immune response to a booster dose of SARS-CoV-2 mRNA-1273 vaccine in kidney transplant recipients. Front Immunol. 2023;14:1111569.","DOI":"10.3389\/fimmu.2023.1111569"},{"key":"3214_CR13","doi-asserted-by":"publisher","first-page":"e304","DOI":"10.1097\/TP.0000000000004126","volume":"106","author":"F Villanego","year":"2022","unstructured":"Villanego F, Vigara LA, Alonso M, Orellana C, G\u00f3mez AM, Eady M, S\u00e1nchez MG, G\u00f3mez R, Garc\u00eda T, Mazuecos A. Trends in COVID-19 Outcomes in Kidney Transplant Recipients During the Period of Omicron Variant Predominance. Transplantation. 2022;106:e304\u20135.","journal-title":"Transplantation"},{"key":"3214_CR14","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.cell.2022.12.018","volume":"186","author":"Q Wang","year":"2023","unstructured":"Wang Q, Iketani S, Li Z, Liu L, Guo Y, Huang Y, Bowen AD, Liu M, Wang M, Yu J, Valdez R, Lauring AS, Sheng Z, Wang HH, Gordon A, Liu L, Ho DD. Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants. Cell. 2023;186:279\u201386.","journal-title":"Cell"},{"key":"3214_CR15","doi-asserted-by":"publisher","first-page":"118","DOI":"10.3390\/vaccines12020118","volume":"12","author":"J Gayed","year":"2024","unstructured":"Gayed J, Diya O, Lowry FS, Xu X, Bangad V, Mensa F, Zou J, Xie X, Hu Y, Lu C, Cutler M, Belanger T, Cooper D, Koury K, Anderson AS, T\u00fcreci \u00d6, Sahin U, Swanson KA, Modjarrad K. Gurtman A and Kitchin N on behalf of the C4591054 Study Group. Safety and Immunogenicity of the Monovalent Omicron XBB.1.5-Adapted BNT162b2 COVID-19 Vaccine in Individuals\u2009\u2265\u200912 Years Old: A Phase 2\/3 Trial. Vaccines (Basel). 2024;12:118.","journal-title":"Vaccines (Basel)"},{"key":"3214_CR16","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.chom.2024.01.014","volume":"32","author":"Q Wang","year":"2024","unstructured":"Wang Q, Guo Y, Bowen A, Mellis IA, Valdez R, Gherasim C, Gordon A, Liu L, Ho DD. XBB.1.5 monovalent mRNA vaccine booster elicits robust neutralizing antibodies against XBB subvariants and JN.1. Cell Host Microbe. 2024;32:315\u201321.","journal-title":"Cell Host Microbe"},{"key":"3214_CR17","doi-asserted-by":"publisher","first-page":"e01828","DOI":"10.1128\/JVI.01828-20","volume":"95","author":"C Fenwick","year":"2021","unstructured":"Fenwick C, Croxatto A, Coste AT, Pojer F, Andr\u00e9 C, Pellaton C, Farina A, Campos J, Hacker D, Lau L, Bosch BJ, Gonseth Nussle S, Bochud M, D\u2019Acremont V, Trono D, Greub G, Pantaleo G. Changes in SARS-CoV-2 Spike versus Nucleoprotein Antibody Responses Impact the Estimates of Infections in Population-Based Seroprevalence Studies. J Virol. 2021;95:e01828\u201320.","journal-title":"J Virol"},{"key":"3214_CR18","doi-asserted-by":"publisher","first-page":"eabi8452","DOI":"10.1126\/scitranslmed.abi8452","volume":"13","author":"C Fenwick","year":"2021","unstructured":"Fenwick C, Turelli P, Pellaton C, Farina A, Campos J, Raclot C, Pojer F, Cagno V, Gonseth Nussl\u00e9 S, D\u2019Acremont V, Fehr J, Puhan M, Pantaleo G, Trono D. A high-throughput cell- and virus-free assay shows reduced neutralization of SARS-CoV-2 variants by COVID-19 convalescent plasma. Sci Transl Med. 2021;13:eabi8452.","journal-title":"Sci Transl Med"},{"key":"3214_CR19","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/ni.2789","volume":"15","author":"S Li","year":"2014","unstructured":"Li S, Rouphael N, Duraisingham S, Romero-Steiner S, Presnell S, Davis C, Schmidt DS, Johnson SE, Milton A, Rajam G, Kasturi S, Carlone GM, Quinn C, Chaussabel D, Palucka AK, Mulligan MJ, Ahmed R, Stephens DS, Nakaya HI, Pulendran B. Molecular signatures of antibody responses derived from a systems biology study of five human vaccines. Nat Immunol. 2014;15:195\u2013204.","journal-title":"Nat Immunol"},{"key":"3214_CR20","doi-asserted-by":"publisher","first-page":"12176","DOI":"10.1038\/s41598-024-63147-z","volume":"14","author":"K Kawashiro","year":"2024","unstructured":"Kawashiro K, Suzuki R, Nogimori T, Tsujino S, Iwahara N, Hirose T, Okada K, Yamamoto T, Fukuhara T, Hotta K, Shinohara N. Neutralizing antibody responses and cellular responses against SARS-CoV-2 Omicron subvariants after mRNA SARS-CoV-2 vaccination in kidney transplant recipients. Sci Rep. 2024;14:12176.","journal-title":"Sci Rep"},{"key":"3214_CR21","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1016\/j.immuni.2023.04.012","volume":"56","author":"M Koutsakos","year":"2023","unstructured":"Koutsakos M, Ellebedy AH. Immunological imprinting: Understanding COVID-19. Immunity. 2023;56:909\u201313.","journal-title":"Immunity"},{"key":"3214_CR22","doi-asserted-by":"crossref","unstructured":"Tortorici A, Addetia A, Seo AJ, Brown J, Sprouse K, Logue J, Clark E, Franko N, Chu H, Veesler D. Persistent immune imprinting occurs after vaccination with the COVID-19 XBB.1.5 mRNA booster in humans. Immunity. 2024;57:904\u201311.","DOI":"10.1016\/j.immuni.2024.02.016"},{"key":"3214_CR23","doi-asserted-by":"publisher","first-page":"e0360724","DOI":"10.1128\/mbio.03607-24","volume":"16","author":"JM Carre\u00f1o","year":"2025","unstructured":"Carre\u00f1o JM, Lerman B, Singh G, Abbad A, Yellin T, Ehrenhaus J, Fried M, Nardulli JR, Kang HM, Mulder LCF, Gleason C, Srivastava K, PVI study group, Simon V, Krammer F. XBB.1.5 monovalent vaccine induces lasting cross-reactive responses to SARS-CoV-2 variants such as HV.1 and JN.1, as well as SARS-CoV-1, but elicits limited XBB.1.5 specific antibodies. mBio. 2025;16:e0360724.","journal-title":"mBio"},{"key":"3214_CR24","doi-asserted-by":"publisher","first-page":"eade2798","DOI":"10.1126\/sciimmunol.ade2798","volume":"8","author":"P Irrgang","year":"2023","unstructured":"Irrgang P, Gerling J, Kocher K, Lapuente D, Steininger P, Habenicht K, Wytopil M, Beileke S, Sch\u00e4fer S, Zhong J, Ssebyatika G, Krey T, Falcone V, Sch\u00fclein C, Peter AS, Nganou-Makamdop K, Hengel H, Held J, Bogdan C, \u00dcberla K, Schober K, Winkler TH, Tenbusch M. Class switch toward noninflammatory, spike-specific IgG4 antibodies after repeated SARS-CoV-2 mRNA vaccination. Sci Immunol. 2023;8:eade2798.","journal-title":"Sci Immunol"},{"key":"3214_CR25","doi-asserted-by":"crossref","unstructured":"Juarez I, P\u00e9rez-Flores I, Aiffil Meneses AS, Lopez-Gomez A, Calvo Romero N, Rodr\u00edguez-Cubillo B, de la Moreno MA, Peix-Jim\u00e9nez B, Gonzalez-Garcia R, Amor\u00f3s-P\u00e9rez B, Rivas-Pardo B, Baos-Mu\u00f1oz E, Arribi Vilela A, G\u00f3mez, Del Moral M, S\u00e1nchez-Fructuoso AI, Mart\u00ednez-Naves E. Immunosuppressive Therapy Modifies Anti-Spike IgG Subclasses Distribution After Four Doses of mRNA Vaccination in a Cohort of Kidney Transplant Recipients. Vaccines (Basel). 2025;13:123.","DOI":"10.3390\/vaccines13020123"},{"key":"3214_CR26","doi-asserted-by":"publisher","first-page":"1020844","DOI":"10.3389\/fimmu.2022.1020844","volume":"13","author":"JS Buhre","year":"2023","unstructured":"Buhre JS, Pongracz T, K\u00fcnsting I, Lixenfeld AS, Wang W, Nouta J, Lehrian S, Schmelter F, Lunding HB, D\u00fchring L, Kern C, Petry J, Martin EL, F\u00f6h B, Steinhaus M, von Kopylow V, Sina C, Graf T, Rahm\u00f6ller J, Wuhrer M, Ehlers M. mRNA vaccines against SARS-CoV-2 induce comparably low long-term IgG Fc galactosylation and sialylation levels but increasing long-term IgG4 responses compared to an adenovirus-based vaccine. Front Immunol. 2023;13:1020844.","journal-title":"Front Immunol"},{"key":"3214_CR27","doi-asserted-by":"publisher","first-page":"520","DOI":"10.3389\/fimmu.2014.00520","volume":"5","author":"G Vidarsson","year":"2014","unstructured":"Vidarsson G, Dekkers G, Rispens T. IgG subclasses and allotypes: from structure to effector functions. Front Immunol. 2014;5:520.","journal-title":"Front Immunol"},{"key":"3214_CR28","doi-asserted-by":"publisher","first-page":"941","DOI":"10.3390\/v14050941","volume":"14","author":"ZR Korobova","year":"2022","unstructured":"Korobova ZR, Zueva EV, Arsentieva NA, Batsunov OK, Liubimova NE, Khamitova IV, Kuznetsova RN, Rubinstein AA, Savin TV, Stanevich OV, Kulikov AN, Pevtsov DE, Totolian AA. Changes in Anti-SARS-CoV-2 IgG Subclasses over Time and in Association with Disease Severity. Viruses. 2022;14:941.","journal-title":"Viruses"},{"key":"3214_CR29","doi-asserted-by":"publisher","first-page":"1513175","DOI":"10.3389\/fimmu.2025.1513175","volume":"16","author":"J Sop","year":"2025","unstructured":"Sop J, Mercado A, Figueroa A, Beckey TP, Traut CC, Zhang L, Smith KN, Blankson JN. The XBB.1.5 mRNA booster vaccine does not significantly increase the percentage of XBB.1.5 mono-reactive T cells. Front Immunol. 2025;16:1513175.","journal-title":"Front Immunol"},{"key":"3214_CR30","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1038\/s41586-020-2814-7","volume":"586","author":"U Sahin","year":"2020","unstructured":"Sahin U, Muik A, Derhovanessian E, Vogler I, Kranz LM, Vormehr M, Baum A, Pascal K, Quandt J, Maurus D, Brachtendorf S, L\u00f6rks V, Sikorski J, Hilker R, Becker D, Eller AK, Gr\u00fctzner J, Boesler C, Rosenbaum C, K\u00fchnle MC, Luxemburger U, Kemmer-Br\u00fcck A, Langer D, Bexon M, Bolte S, Karik\u00f3 K, Palanche T, Fischer B, Schultz A, Shi PY, Fontes-Garfias C, Perez JL, Swanson KA, Loschko J, Scully IL, Cutler M, Kalina W, Kyratsous CA, Cooper D, Dormitzer PR, Jansen KU. T\u00fcreci \u00d6. COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses. Nature. 2020;586:594\u201399.","journal-title":"Nature"},{"key":"3214_CR31","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1016\/j.immuni.2021.08.001","volume":"54","author":"MM Painter","year":"2021","unstructured":"Painter MM, Mathew D, Goel RR, Apostolidis SA, Pattekar A, Kuthuru O, Baxter AE, Herati RS, Oldridge DA, Gouma S, Hicks P, Dysinger S, Lundgreen KA, Kuri-Cervantes L, Adamski S, Hicks A, Korte S, Giles JR, Weirick ME, McAllister CM, Dougherty J, Long S, D\u2019Andrea K, Hamilton JT, Betts MR, Bates P, Hensley SE, Grifoni A, Weiskopf D, Sette A, Greenplate AR, Wherry EJ. Rapid induction of antigen-specific CD4\u2009+\u2009T cells is associated with coordinated humoral and cellular immunity to SARS-CoV-2 mRNA vaccination. Immunity. 2021;54:2133\u201342.","journal-title":"Immunity"},{"key":"3214_CR32","doi-asserted-by":"publisher","first-page":"114593","DOI":"10.1016\/j.isci.2025.114593","volume":"29","author":"R Thi\u00e9baut","year":"2026","unstructured":"Thi\u00e9baut R, Lhomme E, Hocini H, Pellegrin I, Boizard-Moracchini A, Duvignaud A, Perp\u00e8re M, Huchon M, Prague M, Lacabaratz C, Surenaud M, Anglaret X, Malvy D, Hejblum BP, Levy Y, COVERAGE study group. Self-collected finger-prick blood for gene expression profiling: Unveiling early immune responses in mild COVID-19. iScience. 2026;29:114593.","journal-title":"iScience"},{"key":"3214_CR33","doi-asserted-by":"crossref","unstructured":"Rinchai D, Deola S, Zoppoli G, Ahamed Kabeer BS, Taleb S, Pavlovski I, Maacha S, Gentilcore G, Toufiq M, Mathew L, Liu L, Rehaman Vempalli F, Mubarak G, Lorenz S, Sivieri I, Cirmena G, Dentone C, Cuccarolo P, Giacobbe DR, Baldi F, Garbarino A, Cigolini B, Cremonesi P, Bedognetti M, Ballestrero A, Bassetti M, Hejblum BP, Augustine T, Van Panhuys N, Thiebaut R, Branco R, Chew T, Shojaei M, Short K, Feng CG; PREDICT-19 Consortium;, Zughaier SM, De Maria A, Tang B, Ait Hssain A, Bedognetti D, Grivel JC, Chaussabel D. High\u2013temporal resolution profiling reveals distinct immune trajectories following the first and second doses of COVID-19 mRNA vaccines. Sci Adv. 2022;8:eabp9961.","DOI":"10.1126\/sciadv.abp9961"},{"key":"3214_CR34","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/s43856-022-00083-x","volume":"2","author":"L Knabl","year":"2022","unstructured":"Knabl L, Lee HK, Wieser M, Mur A, Zabernigg A, Knabl L, Sr, Rauch S, Bock M, Schumacher J, Kaiser N, Furth PA, Hennighausen L. BNT162b2 vaccination enhances interferon-JAK-STAT-regulated antiviral programs in COVID-19 patients infected with the SARS-CoV-2 Beta variant. Commun Med (Lond). 2022;2:17.","journal-title":"Commun Med (Lond)"}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12985-026-03214-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-026-03214-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-026-03214-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T03:21:35Z","timestamp":1786504895000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12985-026-03214-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,7]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3214"],"URL":"https:\/\/doi.org\/10.1186\/s12985-026-03214-1","relation":{},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,7]]},"assertion":[{"value":"6 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All patients gave written informed consent for the collection, storage, and use of biological samples and all methods were performed in accordance with the relevant guidelines and regulations. This study was conducted following the principles of the Declaration of Helsinki, 1996. The study protocol was approved by the French Ethics Committee CPP-Ile-de-France VI (No. IDRCB: 2018-A01610-55).","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"192"}}